US Map / Tennessee
State TN

Clinical Trials in Tennessee

Recruiting clinical trials with at least one study location in Tennessee. Data updated daily from ClinicalTrials.gov.

Total Trials
264
Recruiting Now
264
← Back to US Map
Top Conditions in Tennessee
Colorectal Cancer (8)Breast Cancer (7)Cancer (7)Prostate Cancer (5)Malignant Solid Neoplasm (5)Advanced Solid Tumor (5)Solid Tumor (5)Ovarian Cancer (4)Endometrial Cancer (4)Obesity (4)Acute Myeloid Leukemia (4)Ewing Sarcoma (4)
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
View Trial →
NCT05505110 EARLY_Phase 1
Recruiting
MOdification Of THe Early-Life Respiratory Microbiome Through Vaginal SEEDing
Condition
C-section
Enrollment
20 pts
Location
United States
Sponsor
Vanderbilt University Medical
View Trial →
NCT04831580 N/A
Recruiting
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Condition
Cervical Cancer
Enrollment
840 pts
Location
United States, Canada
Sponsor
GOG Foundation
View Trial →
NCT06481891 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obst...
Condition
Obstructive Cardiomyopathy, Hypertrophic
Enrollment
500 pts
Location
United States, Argentina, Belgium
Sponsor
Lexicon Pharmaceuticals
View Trial →
NCT05334069 N/A
Recruiting
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests...
Condition
Acute Lymphoblastic Leukemia
Enrollment
2,000 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03932786 N/A
Recruiting
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
Condition
Retinoblastoma
Enrollment
900 pts
Location
United States, Canada
Sponsor
Vanderbilt-Ingram Cancer Cente
View Trial →
NCT06091254 Phase 3
Recruiting
A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Work...
Condition
Follicular Lymphoma (FL)
Enrollment
822 pts
Location
United States, Australia, Austria
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT06613360 Phase 1
Recruiting
A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, ...
Condition
SLE
Enrollment
24 pts
Location
United States, Australia, Bulgaria
Sponsor
Cullinan Therapeutics Inc.
View Trial →
NCT06370182 N/A
Recruiting
Safety and Effectiveness of Mechanical Thrombectomy Using the Anaconda ANA Funne...
Condition
Acute Ischemic Stroke From Large Vessel Occlusion
Enrollment
327 pts
Location
United States, France, Hungary
Sponsor
Anaconda Biomed S.L.
View Trial →
NCT06029660 N/A
Recruiting
AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of...
Condition
Aortic Aneurysm, Abdominal
Enrollment
180 pts
Location
United States, France, Netherlands
Sponsor
Shape Memory Medical, Inc.
View Trial →
NCT06501196 Phase 1
Recruiting
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Highe...
Condition
Leukemia
Enrollment
170 pts
Location
United States
Sponsor
BlossomHill Therapeutics
View Trial →
NCT05561127 Phase 3
Recruiting
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
Condition
Bowel; Stricture
Enrollment
171 pts
Location
United States
Sponsor
GIE Medical
View Trial →
NCT04743141 Phase 3
Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatme...
Condition
Acute Treatment of Migraine
Enrollment
600 pts
Location
United States, Poland, Spain
Sponsor
Pfizer
View Trial →
NCT05785754 Phase 1
Recruiting
DCSZ11 as a Monotherapy and in Combination in Patients With Advanced or Metastat...
Condition
Advanced or Metastatic Solid Tumors
Enrollment
320 pts
Location
United States, Australia, South Korea
Sponsor
DynamiCure Biotechnology
View Trial →
NCT07323654 Phase 2
Recruiting
A Study of KT-621 Administered Orally to Adult Participants With Moderate to Sev...
Condition
Eosinophilic Asthma
Enrollment
264 pts
Location
United States
Sponsor
Kymera Therapeutics, Inc.
View Trial →
NCT06895070 N/A
Recruiting
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Ac...
Condition
Heart Transplant
Enrollment
60 pts
Location
United States
Sponsor
XVIVO Perfusion
View Trial →
NCT06072482 Phase 4
Recruiting
A Study to Evaluate Avacopan in Participants With ANCA-associated Vasculitis
Condition
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Enrollment
300 pts
Location
United States, Czechia, Hungary
Sponsor
Amgen
View Trial →
NCT07219173 Phase 2
Recruiting
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With...
Condition
Asthma
Enrollment
531 pts
Location
United States, Argentina, Brazil
Sponsor
Eli Lilly and Company
View Trial →
NCT05572073 N/A
Recruiting
Otoferlin Gene-mediated Hearing Loss Natural History Study
Condition
Sensorineural Hearing Loss, Bilateral
Enrollment
150 pts
Location
United States, Australia, Germany
Sponsor
Akouos, Inc.
View Trial →
NCT07115069 N/A
Recruiting
Comparison of Body Composition Changes With Weight Loss Interventions
Condition
Obesity
Enrollment
60 pts
Location
United States
Sponsor
Vanderbilt University Medical
View Trial →
NCT06356571 Phase 2
Recruiting
A Study to Investigate Subcutaneous Isatuximab in Combination With Weekly Carfil...
Condition
Plasma Cell Myeloma Refractory
Enrollment
64 pts
Location
United States
Sponsor
Sanofi
View Trial →
NCT04870944 Phase 1, Phase 2
Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS ...
Condition
Diffuse Midline Glioma, H3 K27-Altered
Enrollment
63 pts
Location
United States, Australia
Sponsor
Children's Oncology Group
View Trial →
NCT06410209 Phase 2
Recruiting
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervent...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
190 pts
Location
United States, Puerto Rico
Sponsor
Children's Oncology Group
View Trial →
NCT06813911 Phase 3
Recruiting
Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Partic...
Condition
Atherosclerotic Cardiovascular Disease (ASCVD)
Enrollment
340 pts
Location
United States, China, France
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT07116434 N/A
Recruiting
Discovery Diabetes
Condition
Type 1 Diabetes
Enrollment
150 pts
Location
United States
Sponsor
Vanderbilt University Medical
View Trial →
Page 2 of 11 — 264 trials total
← Prev Next →